CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Comparable long-term efficacy, as assessed by patient-reported outcomes, safety and pharmacokinetics, of CT-P13 and reference infliximab in patients with ankylosing spondylitis: 54-week results from the randomized, parallel-group PLANETAS study
Authors
A Nast
Andriy Gnylorybov
+38 more
AR Giardina
Carlos Abud-Mendoza
D Heijde van der
D Heijde van der
Dae Hyun Yoo
Daina Andersone
DH Yoo
DH Yoo
EW St Clair
F Baert
F Bosch Van Den
F-C Zhang
Francisco Blanco
H Marzo-Ortega
Irmgadt Goecke Sariego
J Braun
J Braun
J Braun
Jan Brzezicki
Janusz Jaworski
Jürgen Braun
M Breban
M Schiff
MA Quinn
P Putrik
PE Lipsky
R Westhovens
RN Maini
S Linden van der
Seong Wook Kang
Seung Suh Hong
SK Jung
Sun Hee Lee
T Abe
Vladimir Kadinov
W Park
William Jose Otero Escalante
Won Park
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1186%2Fs13075-016-...
Last time updated on 05/06/2019